# Ernexa Therapeutics Inc.: Form 8-K, filed Dec 9, 2013

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2013-12-09
- Accepted by EDGAR: Dec 9, 2013, 15:11 ET
- Period: 2013-12-03
- Accession: 0001019687-13-004756
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000101968713004756/ntn_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000101968713004756/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000101968713004756/ntn_8k.htm

Filed Dec 9, 2013.
Source: SEC EDGAR, the filing index for accession 0001019687-13-004756. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.